Your browser doesn't support javascript.
loading
Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.
Wong, Hong Yuen; Sheng, Quanhu; Hesterberg, Amanda B; Croessmann, Sarah; Rios, Brenda L; Giri, Khem; Jackson, Jorgen; Miranda, Adam X; Watkins, Evan; Schaffer, Kerry R; Donahue, Meredith; Winkler, Elizabeth; Penson, David F; Smith, Joseph A; Herrell, S Duke; Luckenbaugh, Amy N; Barocas, Daniel A; Kim, Young J; Graves, Diana; Giannico, Giovanna A; Rathmell, Jeffrey C; Park, Ben H; Gordetsky, Jennifer B; Hurley, Paula J.
Afiliación
  • Wong HY; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Sheng Q; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Hesterberg AB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Croessmann S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rios BL; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Giri K; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Jackson J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Miranda AX; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Watkins E; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Schaffer KR; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Donahue M; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Winkler E; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Penson DF; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Smith JA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Herrell SD; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Luckenbaugh AN; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Barocas DA; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kim YJ; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Graves D; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Giannico GA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Rathmell JC; Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Park BH; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Gordetsky JB; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Hurley PJ; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Nat Commun ; 13(1): 6036, 2022 10 13.
Article en En | MEDLINE | ID: mdl-36229464
ABSTRACT
Cribriform prostate cancer, found in both invasive cribriform carcinoma (ICC) and intraductal carcinoma (IDC), is an aggressive histological subtype that is associated with progression to lethal disease. To delineate the molecular and cellular underpinnings of ICC/IDC aggressiveness, this study examines paired ICC/IDC and benign prostate surgical samples by single-cell RNA-sequencing, TCR sequencing, and histology. ICC/IDC cancer cells express genes associated with metastasis and targets with potential for therapeutic intervention. Pathway analyses and ligand/receptor status model cellular interactions among ICC/IDC and the tumor microenvironment (TME) including JAG1/NOTCH. The ICC/IDC TME is hallmarked by increased angiogenesis and immunosuppressive fibroblasts (CTHRC1+ASPN+FAP+ENG+) along with fewer T cells, elevated T cell dysfunction, and increased C1QB+TREM2+APOE+-M2 macrophages. These findings support that cancer cell intrinsic pathways and a complex immunosuppressive TME contribute to the aggressive phenotype of ICC/IDC. These data highlight potential therapeutic opportunities to restore immune signaling in patients with ICC/IDC that may afford better outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma Intraductal no Infiltrante Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos